Mitolife Radio
Mitolife Radio
Jan 29, 2021
Hyperbaric Oxygen Therapy and Methylene Blue with Dr Scott Sherr
Play • 2 hr 9 min

The first documented use of hyperbaric oxygen therapy, or HBOT, was in 1662. It didn’t gain traction until the 1930s when the US Navy began using it to treat scuba divers with decompression sickness (the bends). 

Since then, there have been over 800 clinical studies conducted on the therapy, with benefits ranging from treatment of chronic wounds, infections, mold exposure, autism, traumatic brain injury, stroke, diabetes, and more.

Dr. Scott Sherr is an integrative medicine practitioner that has been studying HBOT for over a decade. He utilizes HBOT, methylene blue and other modalities in his practice to help bring people back into balance and improve their quality of life.  In this interview he talks about neuroplasticity, hypoxic inducible factor, EZ water, mitochondria and oxygen overall as it works in the body. He also clears up a lot of the misconceptions about hyperbaric oxygen therapy.  Scott Sherr's website: My chamber: Mention my name to save $ Order Blue Cannatine or Just Blue methylene blue: Use the discount code BLACKBURN to save 10% My website: Order Mitolife products: Use the discount code FIRSTTIME to save 15% on your first order Music by George Henner


More episodes
Clear search
Close search
Google apps
Main menu